OPEN END TURBO PUT WARRANT - AMGEN | Market Closed - Deutsche Boerse AG 01:32:16 2024-05-17 pm EDT | ||
| 0.71 EUR | +1.43% |
|
| Current month | -36.04% | ||
| 1 month | -40.83% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-17 | 0.71 | +1.43% |
| 24-05-16 | 0.7 | +4.48% |
| 24-05-15 | 0.67 | -14.10% |
| 24-05-14 | 0.78 | -1.27% |
| 24-05-13 | 0.79 | +5.33% |
Delayed Quote Deutsche Boerse AG
Last update May 17, 2024 at 01:32 pm EDT
More quotesStatic data
| Product type | Warrant Knock-Out senza Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | UBS |
| WKN | UK97HV |
| ISIN | DE000UK97HV9 |
| Date issued | 2022-11-22 |
| Strike | 391 $ |
| Maturity | Unlimited |
| Parity | 100 : 1 |
| Emission price | 1.15 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.73 € |
|---|---|
| Lowest since issue | 0.63 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
312.5
USD
Average target price
314.1
USD
Spread / Average Target
+0.51%
- Stock Market
- Certificates
- Certificat
